Equities

Indoco Remedies Ltd

INDOCO:NSI

Indoco Remedies Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (INR)377.10
  • Today's Change4.15 / 1.11%
  • Shares traded61.91k
  • 1 Year change+10.62%
  • Beta0.6257
Data delayed at least 15 minutes, as of Sep 20 2024 11:26 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of INR
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
ASSETS
Cash And Short Term Investments221119168
Total Receivables, Net5,2834,4183,228
Total Inventory3,7213,4283,223
Prepaid expenses20311695
Other current assets, total119551,022
Total current assets9,5478,1367,736
Property, plant & equipment, net8,9116,6765,847
Goodwill, net2150.900.90
Intangibles, net1,6651,242919
Long term investments15150.23
Note receivable - long term984439212
Other long term assets9251125
Total assets21,44716,58214,861
LIABILITIES
Accounts payable1,5361,2351,333
Accrued expenses1,093803263
Notes payable/short-term debt2,5661,1841,037
Current portion long-term debt/capital leases473549461
Other current liabilities, total4554761,154
Total current liabilities6,1234,2454,249
Total long term debt3,6411,5851,068
Total debt6,6803,3182,567
Deferred income tax11861106
Minority interest5.970--
Other liabilities, total459408392
Total liabilities10,3486,2995,815
SHAREHOLDERS EQUITY
Common stock184184184
Additional paid-in capital650642642
Retained earnings (accumulated deficit)10,2639,4568,220
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total2.31(0.02)--
Total equity11,09910,2839,046
Total liabilities & shareholders' equity21,44716,58214,861
Total common shares outstanding929292
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.